malignant tumor
Conditions
Interventions
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Age
75 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients aged 75 years or older; 2. Immune checkpoint inhibitor therapy has been administered; 3. There are basic clinical information before treatment (gender and age, etc.), medical history (current and past medical history), laboratory tests (blood routine, liver and kidney function, coagulation function, etc.), and histological or cytological pathological diagnosis results of confirmed malignant tumors, regardless of tumor type.
Exclusion criteria
Exclusion criteria: 1. Combination of other treatment methods (such as chemotherapy and targeted therapy) during the application of immunotherapy; 2. Biological immunotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the receiver operating characteristic curve (AUC-ROC);Toxicity prediction accuracy; | — |
Countries
China
Contacts
Public ContactXu Yan
Beijing Hospital
Outcome results
None listed